Sars-cov-2 infection among patients with underlying haematological disorders

Risk factors for developing corona virus disease 2019 (COVID-19) infection in patients with hematological disorders are numerous. Those patients receive immunosuppressive therapy and are at increased risk of both community- and hospital-acquired infections1,2. Additionally hospitalized persons with hematological cancers have more severe disease and higher mortality when compared with normal health care providers3. Current recommendations advise management of patients with hematological disorders on a case-by-case basis4,5. Here, we report a case series of patients with hematological disorders infected by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) with variable clinical outcome. © 2021 Bulgarian Medical Society of Hematology. All rights reserved.